Ausgabe 6/2009
Inhalt (8 Artikel)
Osteopontin: a new emerging role in psoriasis
Elisabetta Buommino, Maria Antonietta Tufano, Nicola Balato, Nunzia Canozo, Maria Donnarumma, Lucia Gallo, Anna Balato, Fabio Ayala
Apolipoprotein E gene polymorphism in psoriasis
Anthony Karpouzis, Rozina Caridha, Gregory Tripsianis, Charalambos Michailidis, George Martinis, Stavroula Vouliana Veletza
Isolation of Leishmania amastigote protein fractions which induced lymphocyte stimulation and remission of psoriasis
Jose Antonio O’Daly, R. Lezama, J. Gleason
Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumab
Robert Bissonnette, Richard G. Langley, Kim Papp, Robert Matheson, Darryl Toth, Micki Hultquist, Gregory P. Geba, Barbara White
Analysis of a functional serotonin transporter promoter polymorphism in psoriasis vulgaris
Rotraut Mössner, Gerthild Stiens, Inke R. König, Diane Schmidt, Anja Platzer, Ullrich Krüger, Kristian Reich
The serotonin transporter protein is expressed in psoriasis, where it may play a role in regulating apoptosis
Kristofer Thorslund, Husameldin El-Nour, Klas Nordlind
Therapeutic effects of heme oxygenase-1 on psoriasiform skin lesions in guinea pigs
L. J. Ma, Y. You, B. X. Bai, Yu-Zhen Li
Matrix metalloproteinase-2 promoter variability in psoriasis
Vladimir Vasku, Julie Bienertova Vasku, Veronika Slonková, Kateřina Kaňková, Anna Vasku